Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs.
about
Sodium channel blockers for neuroprotection in multiple sclerosisSodium channel blockers for neuroprotection in multiple sclerosisTherapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosisThe Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platformNonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.Clinical trials in progressive multiple sclerosis: lessons learned and future perspectivesEliminating encephalitogenic T cells without undermining protective immunityBlocking initial infiltration of pioneer CD8(+) T-cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice.Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.Molecular insights for optimizing T cell receptor specificity against cancer.A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT's) in multiple sclerosis (MS)Maximizing gait and balance: behaviors and decision-making processes of persons with multiple sclerosis and physical therapists.Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.Feasibility and Effects of Structured Physical Exercise Interventions in Adults with Relapsing-Remitting Multiple Sclerosis: A Pilot Study
P2860
Q24186448-1ED4CCE6-C672-480D-9A0A-30ABF599644AQ24200461-BAE4A3FD-7067-4BAD-923B-3F2E28D8D7D6Q28066677-721D6422-9970-47F7-AB2C-B95A50FADEC1Q28488248-E3359F06-D9E8-43CF-BA26-61790EA749F2Q30871249-C58D5E4C-9FEF-4EE1-9C42-0BF40A68BBE3Q35182733-CE545DD1-F258-499C-9122-31C84C653875Q37412980-5BD7B3DA-7FBE-45AB-B1BC-C61C779228F8Q37665608-393AE6B2-9312-45E0-AFCA-6E27BB1AFEFFQ38052870-C5DB3417-7CD7-4149-8CAA-AAB072465ECCQ38068514-9E5DEE18-A0DB-47A2-8FB9-0883CBEA647BQ38117139-DAEE5DAE-57CF-4F1B-943C-975805D760C4Q38637755-6F54C7B2-9937-47CE-A718-693B0FC42603Q38715406-8C31C452-E33F-41C8-8C9A-8C0D834AEC0DQ48607199-E8250CED-6AA6-4BEF-8FE6-B44AEA63C27BQ58783646-FBFCCDAE-F7C3-452A-92D5-6260F2934AB0
P2860
Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs.
@en
Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs.
@nl
type
label
Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs.
@en
Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs.
@nl
prefLabel
Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs.
@en
Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs.
@nl
P1476
Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs.
@en
P2093
Aaron E Miller
Robert W Rhoades
P356
10.1097/01.WCO.0000413319.87092.19
P478
P577
2012-02-01T00:00:00Z